Coherus Completes $50m Share Offer To Novel Partner Junshi Biosciences

Follows Immuno-Oncology Collaboration Agreement In February

 
• By Dean Rudge

Coherus BioSciences has sold a little under 2.5 million shares to partner Junshi Biosciences, giving the firm additional capital following a large debt financing last year.

US-Money-and-Pills_V2_1200x675
Junshi has acquired 2,491,988 Coherus shares for US$20.06 per share • Source: Shutterstock

More from Deals

More from Business